IL59003A - Enteric coated oral pharmaceutical compositions comprising ergot alkaloids and polyalkoxyalkylene sterol ethers - Google Patents

Enteric coated oral pharmaceutical compositions comprising ergot alkaloids and polyalkoxyalkylene sterol ethers

Info

Publication number
IL59003A
IL59003A IL59003A IL5900379A IL59003A IL 59003 A IL59003 A IL 59003A IL 59003 A IL59003 A IL 59003A IL 5900379 A IL5900379 A IL 5900379A IL 59003 A IL59003 A IL 59003A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
enteric coated
oral pharmaceutical
ergot alkaloids
coated oral
Prior art date
Application number
IL59003A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL59003A publication Critical patent/IL59003A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL59003A 1978-12-21 1979-12-19 Enteric coated oral pharmaceutical compositions comprising ergot alkaloids and polyalkoxyalkylene sterol ethers IL59003A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1302178 1978-12-21
CH1301978 1978-12-21
CH56679 1979-01-19
CH56779 1979-01-19

Publications (1)

Publication Number Publication Date
IL59003A true IL59003A (en) 1982-12-31

Family

ID=27427929

Family Applications (1)

Application Number Title Priority Date Filing Date
IL59003A IL59003A (en) 1978-12-21 1979-12-19 Enteric coated oral pharmaceutical compositions comprising ergot alkaloids and polyalkoxyalkylene sterol ethers

Country Status (23)

Country Link
AT (1) AT372279B (no)
AU (1) AU534051B2 (no)
CA (1) CA1139222A (no)
CH (1) CH642259A5 (no)
CY (1) CY1330A (no)
DE (1) DE2950154A1 (no)
DK (1) DK154607C (no)
FI (1) FI793888A (no)
FR (1) FR2444463A1 (no)
GB (1) GB2038181B (no)
HK (1) HK37986A (no)
HU (1) HU182577B (no)
IE (1) IE49323B1 (no)
IL (1) IL59003A (no)
IT (1) IT1164029B (no)
KE (1) KE3617D (no)
MY (1) MY8500129A (no)
NL (1) NL187229C (no)
NZ (1) NZ192457A (no)
PH (1) PH25178A (no)
PT (1) PT70614A (no)
SE (1) SE442265B (no)
WO (1) WO1980001242A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE14379T1 (de) * 1981-04-27 1985-08-15 Haessle Ab Pharmazeutisches praeparat.
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
DE3413955A1 (de) * 1983-04-22 1984-10-25 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutisches praeparat enthaltend co-dergocrine und einen calcium-antagonisten
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
AT388101B (de) * 1985-02-05 1989-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur oralen verabreichung mit kontrollierter wirkstofffreisetzung
CN1003978B (zh) * 1987-09-05 1989-04-26 广州陈李济药厂 一种补脾益肠丸的制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
DE2528257C2 (de) * 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Also Published As

Publication number Publication date
IT7951153A0 (it) 1979-12-20
CH642259A5 (de) 1984-04-13
DK154607C (da) 1989-06-05
FR2444463B1 (no) 1983-02-25
CY1330A (en) 1986-06-27
HK37986A (en) 1986-05-30
DK154607B (da) 1988-12-05
GB2038181A (en) 1980-07-23
PT70614A (fr) 1980-01-01
HU182577B (en) 1984-02-28
WO1980001242A1 (en) 1980-06-26
DE2950154C2 (no) 1989-05-11
GB2038181B (en) 1983-05-11
IE792471L (en) 1980-06-21
CA1139222A (en) 1983-01-11
IE49323B1 (en) 1985-09-18
ATA803679A (de) 1983-02-15
KE3617D (en) 1986-04-18
AU5403179A (en) 1980-06-26
FI793888A (fi) 1980-06-22
SE7910227L (sv) 1980-06-22
PH25178A (en) 1991-03-27
DE2950154A1 (de) 1980-07-10
AU534051B2 (en) 1984-01-05
DK529879A (da) 1980-06-22
NL7909105A (nl) 1980-06-24
IT1164029B (it) 1987-04-08
AT372279B (de) 1983-09-26
NL187229C (nl) 1991-07-16
FR2444463A1 (fr) 1980-07-18
MY8500129A (en) 1985-12-31
SE442265B (sv) 1985-12-16
NZ192457A (en) 1983-06-17

Similar Documents

Publication Publication Date Title
ZA802620B (en) Steroid alkaloids and pharmaceutical compositions containing them
IL58079A0 (en) Fabrinolytic enzyme derivatives their preparation and pharmaceutical compositions containing them
PH14086A (en) Cyclosporin derivatives and pharmaceutical compositions thereof
IL56411A (en) Derivatives of 4-amino-5-alkylsulphonyl-ortho-anisamides,their preparation and pharmaceutical compositions containing them
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
PT69700A (en) Process for the preparation of inula extract and of a pharmaceutical composition containing the same
IL59003A (en) Enteric coated oral pharmaceutical compositions comprising ergot alkaloids and polyalkoxyalkylene sterol ethers
IL57876A (en) Pharmaceutical compositions of polysaccharide gums
NZ190444A (en) Di-o-n-alkyl glycerol derivatives and pharmaceutical compositions
PH15024A (en) Pharmaceutical compositions containing a xanthine derivatives and method of use
IL58620A0 (en) Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them
NZ192142A (en) Cephalosporin derivatives and pharmaceutical compositions
GB2039277B (en) Preparation of pharmacologically-active piperidylindoles
NZ190245A (en) Isoquinoline derivatives and pharmaceutical compositions containing them
PH17494A (en) New ergoline derivatives and pharmaceutical compositions thereof
GB2015338B (en) Pharmaceutical compositions containg ergot alkaloids and heparing
PH18155A (en) Ergot peptide alkaloid derivatives and pharmaceutical compositions containing them
IL58438A0 (en) Isoquinoline derivatives their preparation and pharmaceutical compositions containing them
NZ189460A (en) 11-hydroxy-17-substituted pregnane derivatives and pharmaceutical compositions
NZ190665A (en) S-benzylcysteine derivatives and pharmaceutical compositions
NZ190007A (en) Steroid-spiro-oxazolidinone derivatives and pharmaceutical compositions
IL58169A0 (en) -alkyl-o-oxybenzylamine derivatives their preparation and pharmaceutical compositions containing them
GB2017096B (en) 8-hydrazinomethylergoline derivatives and pharmaceutical compositions containing them
NZ191718A (en) Preparation of derivatives of diisoeugenols certain of these derivatives pharmaceutical compositions
NZ189770A (en) 2-methoxybenzamide derivatives and pharmaceutical compositions